BenevolentAI
is a leading enabled drug discovery development company with a platform generated pipeline discovery development industry leading platform uncovers novel biology across diseases and drug modalities portfolio of in class and best in class programs discovered using our proprietary platform discovery preclinical clinical expansive knowledge graph with multimodal data foundations disease and drug modality agnostic generate predictions with the aim to increase the probability of success asset in phase assets in platform generated drug programmes enabled | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
5 of 38
Related slides by other companies
Absci
Investor Presentation
March 2023
the leading full stack platform for drug creation | Absci
Absci
Investor Presentation
July 2023
the leading platform for enabled drug creation enabled as a | Absci
Absci
Investor Presentation
March 2023
the leading platform for enabled drug creation enabled | Absci
Absci
Investor Presentation
March 2023
technology validated through industry leading partnerships | Absci
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io